Cardiovascular safety perceptions of sulfonylureas based on evidence
10.3969/j.issn.1006-6187.2017.06.020
- 白话标题:基于循证证据的磺脲类药物心血管安全性认识
- 作者:
Lizhi TANG
;
Nanwei TONG
- 关键字:
Diabetes mellitus,type 2;
Sulfonylureas;
Cardiovascular risk
- 来源:
Chinese Journal of Diabetes
2017;25(6):573-576
- 国家China
- 语言:Chinese
-
摘要:
The relationship between Sulfonylureas(SUs) and cardiovascular (CV) risks has attracted great attention.Previous studies have illustrated that some SUs increase CV risk in type 2 diabetes (T2DM) patients;while others do not.Clinical studies have found that the CV risks of different SUs may be different.Compared with other SUs;glimepiride and gliclazide may have lower CV risks.Here we reviewed evidence-based CV safety of SUs and the recent research progress.
